Allogene Therapeutics, Inc. ALLO
NASDAQ · United States · Health Technology
$1.50-0.04 (-2.60%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.13 | -0.17 | +24.1% | $4.64M | +185,500.0% | -6.6%$2.12→$1.98 |
| Q1 2026 | 2026-05-13 | -0.18 | -0.18 | 0.0% | — | — | -7.0%$2.30→$2.14 |
| Q4 2025 | 2026-03-12 | -0.17 | -0.22 | +22.7% | — | — | -8.7%$2.63→$2.40 |
| Q3 2025 | 2025-11-06 | -0.19 | -0.23 | +17.4% | — | — | +6.3%$1.11→$1.18 |
| Q2 2025 | 2025-08-13 | -0.22 | -0.27 | +18.5% | — | — | — |
| Q1 2025 | 2025-05-13 | -0.28 | -0.29 | +3.4% | — | — | — |
| Q4 2024 | 2025-03-13 | -0.28 | -0.32 | +12.5% | — | — | — |
| Q3 2024 | 2024-11-07 | -0.27 | -0.33 | +18.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.